Surgery Partners receives ‘buy’ rating: 4 quick facts

Analysts rated Nashville, Tenn.-based Surgery Partners shares a “buy,” according to Sports Perspective.

Advertisement

Here are four quick facts:

1. Analysts have a $20.86 one-year price target on Surgery Partners shares.

2. On Jan. 26, 2017, Surgery Partners shares opened the day trading at $19.15 per share.

3. The company’s market cap is $828.64 million.

4. The P/E ratio is 98.71.

More articles on surgery centers:
Surgery Partners opens ophthalmology-driven ASC — 3 highlights
Carle gets green light to relocate ASC — 4 notes
Christ Hospital’s dispute with St. Elizabeth Healthcare over $24M ASC may wage on for years

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.